GLIS3 and type 2 diabetes mellitus: GLIS3 KD increased beta cell apoptosis under basal condition and sensitized cells to death induced by interleukin 1β (IL-1β) + interferon-γ (IFN-γ) or palmitate, agents that may contribute to beta cell loss in respectively T1D and T2D.